Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Moleculin Biotech (MBRX) Return on Invested Capital (2019 - 2020)

Moleculin Biotech's Return on Invested Capital history spans 2 years, with the latest figure at 1.2% for Q4 2020.

  • Quarterly results put Return on Invested Capital at 1.2% for Q4 2020, down 37.0% from a year ago — trailing twelve months through Dec 2020 was 1.2% (down 37.0% YoY), and the annual figure for FY2019 was 1.14%, changed.
  • Return on Invested Capital for Q4 2020 was 1.2% at Moleculin Biotech, up from 1.38% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.83% in Q4 2019 to a low of 1.38% in Q3 2020.